\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
ProgrammesA new report titled “Horizon Europe’s Legal, Financial & Administrative Rules” has been released.
The survey and its analysis was prepared by the Legal & Financial NCP network within the Horizon Academy project. It examines how the legal, financial, and administrative rules of Horizon Europe are applied in daily project activities, a compilation of 1,360 responses from beneficiaries. The findings seek to enhance understanding among stakeholders and contribute to the future development of the programme, including the future Framework Programme (FP10).
Link to the full report
Article summarising some findings
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
